New stent aims to keep heart arteries open longer
NCT ID NCT06071702
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early study tests a new stent that releases a drug to prevent artery re-narrowing in 30 people with coronary artery disease. The stent is placed during a routine procedure to prop open blocked heart vessels. Researchers will check if the artery stays open after 13 months and track any heart-related events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ridaforolimus
What this could lead to
If successful, this stent could offer a new option to keep coronary arteries open and reduce the need for repeat procedures in people with heart disease.
What could go wrong
This is a very early, small study (30 people) that is currently suspended. The stent may not work as intended or could cause complications like blood clots or heart attacks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St Francis Hospital Heart Center
Roslyn, New York, 11576, United States